Nabriva stock up after firm's antibiotic shows promise as a potential cystic fibrosis treatment

The company's stock opened up 9% Monday morning.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.